Ergocalciferol
Pricing Report NDC 0955-0251-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Ergocalciferol (NDC 0955-0251-10) is $0.24745 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 17, 2014.

As a provided by Winthrop U.s., this medication is distributed in a 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.24745
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 17, 2014
Billable Units
100 EA
Estimated Package Price
$24.74
Data Status
As of Dec 31, 2014
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0955-0251-10
Description
100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.23168 to $0.29614 per EA. Over this 1 year period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2317 - $0.2961
Market Volatility
27.82% Variance
Latest Trend
3.09%
Date Unit Price Unit Source Method Rate
Dec 17, 2014 $0.24745 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $0.25535 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2014 $0.23168 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $0.29138 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $0.28809 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $0.29614 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $0.27800 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.28035 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $0.28392 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.29603 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.28016 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $0.28507 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $0.28809 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2013 $0.24729 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026